Glucocorticoid use, older age, male sex and comorbidity burden are among the predictors of more severe COVID-19 in patients with psoriasis, psoriatic arthritis or axial spondyloarthritis, according to data.
Moderate and high disease activity, as well as the use of immunosuppressants, were associated with a higher risk for COVID-related death in patients with rheumatic diseases, according to data in the Annals of the Rheumatic Diseases.The researchers noted that, although the use of most disease-modifying antirheumatic drugs were not linked to higher risk of death from COVID-19, there were